Clinical Trials
180 trialsLeukapheresis for CAR or Adoptive Cell Therapy Manufacturing
National Institutes of Health Clinical Center (CC)
Long-term Follow up Local Registry Study of Kymriah in South Korea
Novartis
REVERSE_2021
Azienda USL Reggio Emilia - IRCCS
GlofitReal
Hoffmann-La Roche
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche
Bio-CAR-T BS Study
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
realMIND
Incyte Corporation
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
Adicet Therapeutics
NEURO_CAR-T
Fondazione Italiana Linfomi - ETS
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
H. Lee Moffitt Cancer Center and Research Institute
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Children's Hospital Medical Center, Cincinnati
EpcoReal
AbbVie
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Emory University
EPKEY_HSR
IRCCS San Raffaele
CS22-03
AIDS Malignancy Consortium
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
City of Hope Medical Center
RUBIN
iOMEDICO AG
Communication Skills Intervention to Promote Transition Into Survivorship
Memorial Sloan Kettering Cancer Center
Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy
Peking Union Medical College Hospital
FIL_MIMYC
Fondazione Italiana Linfomi - ETS
Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Fujian Medical University
Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma
Fujian Medical University
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Medical College of Wisconsin
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
CHARTHER
IRCCS San Raffaele
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
OHSU Knight Cancer Institute
A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Novartis
Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET
Fudan University
Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Novartis
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
AstraZeneca
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Pell Bio-Med Technology Co., Ltd.
MMCI
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
SANGUINE
JaxBio Ltd
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
Celgene
TALOs
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma
Charles University, Czech Republic
PIXBRIDGE
IRCCS Azienda Ospedaliero-Universitaria di Bologna
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
Ruijin Hospital
The Microbiome in Blood Cancer and HLH
University of Nottingham
PREDIC-TO
Fondazione IRCCS San Gerardo dei Tintori
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
Ruijin Hospital
DEL Biomarker
Ruijin Hospital
PC002
Leuko Labs, Inc.
MOSAIC
OWKIN
A Real-World Study on Extranodal Lymphoma
Ruijin Hospital
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Children's Oncology Group